These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35031)

  • 21. The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    Curr Probl Cardiol; 1984 Jun; 9(3):1-50. PubMed ID: 6146495
    [No Abstract]   [Full Text] [Related]  

  • 22. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autonomic regulation involved in the ocular hypotensive action of beta-adrenergic blocking agents.
    Alkondon M; Ray A; Sen P
    J Pharm Pharmacol; 1986 Apr; 38(4):319-22. PubMed ID: 2872303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A toxicological review of beta-adrenergic blockers.
    Jackson CD; Fishbein L
    Fundam Appl Toxicol; 1986 Apr; 6(3):395-422. PubMed ID: 2870945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-Adrenergic receptors and renin release: studies with beta-adrenoreceptor-blocking agents in the conscious rabbit.
    Weber MA; Oates HF; Stokes GS
    Clin Sci Mol Med Suppl; 1975 Jun; 2():89s-91s. PubMed ID: 28880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
    Harms HH; Gooren L; Spoelstra AJ; Hesse C; Verschoor L
    Br J Clin Pharmacol; 1978 Jan; 5(1):19-26. PubMed ID: 23133
    [No Abstract]   [Full Text] [Related]  

  • 27. Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
    Smith ER; Kacker SR; Raskin A; Yun PT; Davidson JM; Hoffman BB; Clark JT
    Physiol Behav; 1996 Feb; 59(2):241-6. PubMed ID: 8838601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
    Coram WM; Olson RW; Beil ME; Cabot CF; Weiss GB
    J Cardiovasc Pharmacol; 1987 May; 9(5):611-21. PubMed ID: 2439844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Action of several -adrenoceptor blocking drugs in the pregnant sheep and foetus.
    Truelove JF; van Petten GR; Willes RF
    Br J Pharmacol; 1973 Jan; 47(1):161-71. PubMed ID: 4146153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition by beta-adrenoceptor blocking agents of calcium uptake into and efflux from isolated sarcoplasmic vesicles.
    Temple DM; Hasselbach W; Makinose M
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(2):187-94. PubMed ID: 4153127
    [No Abstract]   [Full Text] [Related]  

  • 32. Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.
    Lochan R; Silke B; Taylor SH
    Br J Clin Pharmacol; 1981 Nov; 12(5):721-4. PubMed ID: 6120711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):240-52. PubMed ID: 2862847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
    Meier J
    Acta Med Scand Suppl; 1977; 606():65-70. PubMed ID: 19931
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of selective beta 1- and beta 2-adrenoreceptor agonists and antagonists on intraocular pressure in the cat.
    Colasanti BK; Trotter RR
    Invest Ophthalmol Vis Sci; 1981 Jan; 20(1):69-76. PubMed ID: 6108938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative pharmacokinetics of beta-blockers].
    Kiechel JR; Meier J
    Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
    [No Abstract]   [Full Text] [Related]  

  • 39. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers.
    Wettrell K; Pandolfi M
    Exp Eye Res; 1975 Nov; 21(5):451-6. PubMed ID: 1282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.